Observational Study of ALNA® (Tamsulosin) in Patients With Benign Prostatic Hyperplasia (BPH)

Clinical trial NCT02245503 · COMPLETED

Trial details

NCT number: NCT02245503
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Study type: OBSERVATIONAL

Prostatic Hyperplasia

Start date: 2003-05-01
Primary completion: 2003-10-01
Enrollment: 7391

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.